12/12/2022, 1:13 PM (Source: TeleTrader)
more TeleTrader news

Amgen to buy Horizon for $26.4 billion

Amgen Inc. announced on Monday that it would acquire Horizon Therapeutics Plc for $26.4 billion, following earlier speculation on Sunday that hinted at a takeover, after rival bidder Sanofi SA dropped out.

Following the deal, Horizon Therapeutics Plc's value increased to $28.3 billion and gives Amgen Inc. access to several drugs such as Tepezza, a groundbreaking treatment for thyroid eye disease.

The official press release stated that the deal will be effective in early 2023, subject to regulatory approvals.

Baha Breaking News (BBN) / KB